New paper provides important insights into how carcinoma-associated fibroblasts function in breast cancers

by William G. Gilroy
New paper provides important insights into how carcinoma-associated fibroblasts function in breast cancers
Carcinoma-associated fibroblasts (CAFs)

(Medical Xpress)—A new paper by a team of researchers led by Zachary T. Schafer, Coleman Assistant Professor of Cancer Biology in the Department of Biological Sciences at the University of Notre Dame, offers important new insights into the role carcinoma-associated fibroblasts (CAFs) play in tumor biology.

A number of recent studies have revealed CAFs to be a major contributor to tumor progression through a variety of mechanisms. Despite this information, the precise role CAFs play in augmenting the growth of tumors is still poorly understood.

In their new paper, Schafer and his fellow researchers describe a critical role for CAFs in blocking anoikis, a cell death process that inhibits the spread of to distant sites, through the secretion of insulin-like growth factor-binding proteins (IGFBPs). They revealed the precise molecular mechanism utilized by IGFBPs to inhibit anoikis: the stabilization of an anti-cell-death protein called Mcl-1.

"While cells present in the tumor microenvironment are now widely appreciated to actively contribute to tumor progression, our studies have unveiled a novel mechanism by which this can occur," Schafer said. "Therapies designed to hinder this role for IGFBPs might be particularly useful in slowing ."

Schafer noted, however, that additional pre-clinical studies are necessary to better understand which IGFBPs might be amenable to target and to determine the precise point during that IGBFP inhibition could be effective.

The paper was published online on May 7 in the journal Molecular Cancer Research.

More information: "CAF-Secreted IGFBPs Regulate Breast Cancer Cell Anoikis." Kelsey J. Weigel, Ana Jakimenko, Brooke A. Conti, Sarah E. Chapman, William J. Kaliney, W. Matthew Leevy, Matthew M. Champion, and Zachary T. Schafer. Mol Cancer Res Published OnlineFirst May 6, 2014; DOI: 10.1158/1541-7786.MCR-14-0090

Related Stories

Blood-pressure drug may help improve cancer treatment

date Oct 01, 2013

Use of existing, well-established hypertension drugs could improve the outcome of cancer chemotherapy by opening up collapsed blood vessels in solid tumors. In their report in the online journal Nature Co ...

Recommended for you

DNA blood test detects lung cancer mutations

date 12 hours ago

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

Tumors prefer the easy way out

date 15 hours ago

Tumor cells become lethal when they spread. Blocking this process can be a powerful way to stop cancer. Historically, scientists thought that tumor cells migrated by brute force, actively pushing through whatever ...

Brain tumors may be new targets of Ebola-like virus

date 15 hours ago

Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.